These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12182228)

  • 1. Therapeutic strategies for hepatitis B virus-associated hepatocellular carcinoma.
    Wong ET; Chew YP; Lee LA; Lee CG
    Curr Drug Targets; 2002 Oct; 3(5):369-78. PubMed ID: 12182228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.
    Yan SY; Fan JG; Qio L
    Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
    Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
    J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus-related hepatocellular carcinoma presenting at an advanced stage: is it preventable?
    Mules T; Gane E; Lithgow O; Bartlett A; McCall J
    N Z Med J; 2018 Nov; 131(1486):27-35. PubMed ID: 30496164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma: an Asian perspective.
    Teo EK; Fock KM
    Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw.
    Tsubota A; Arase Y; Ren F; Tanaka H; Ikeda K; Kumada H
    J Med Virol; 2001 Oct; 65(2):257-65. PubMed ID: 11536231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma.
    Wang X; Bayer ME; Chen X; Fredrickson C; Cornforth AN; Liang G; Cannon J; He J; Fu Q; Liu J; Nistor GI; Cao W; Chen C; Dillman RO
    J Surg Oncol; 2015 Jun; 111(7):862-7. PubMed ID: 25873455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now.
    Bharadwaj M; Roy G; Dutta K; Misbah M; Husain M; Hussain S
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):229-68. PubMed ID: 23114844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma.
    Jiang E; Shangguan AJ; Chen S; Tang L; Zhao S; Yu Z
    Cancer Lett; 2016 Sep; 379(2):262-7. PubMed ID: 26272181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive T-cell therapy for HBV-associated HCC and HBV infection.
    Tan AT; Schreiber S
    Antiviral Res; 2020 Apr; 176():104748. PubMed ID: 32087191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.
    Wang YG; Huang PP; Zhang R; Ma BY; Zhou XM; Sun YF
    World J Gastroenterol; 2016 Jan; 22(1):326-37. PubMed ID: 26755879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J; Steel LF; Bouchard MJ
    World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for HCV/HBV-induced hepatocellular carcinoma.
    Smerdou C; Menne S; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1368-77. PubMed ID: 21154119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
    Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus.
    Hilleman MR
    Vaccine; 2003 Dec; 21(32):4626-49. PubMed ID: 14585670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.